Seller record · Telehealth service

Metaboost Rx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies. 2 more criteria also fail; see the table below.

At a glance

Metaboost RxTelehealth service

5/8criteria passed
Price
Semaglutide from $149 a month; tirzepatide from $199, was $299 (struck through)
Sells
semaglutide injection, tirzepatide injection, GLP-1 microdose, and 5 more
FDA letters
None on file
Visit Metaboost RxSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

An Oklahoma City telehealth platform selling compounded semaglutide and tirzepatide injections, a GLP-1 microdose program and an oral GLP-1, with tesamorelin, sermorelin, NAD+ and PT-141 on its peptides page. Monthly starting prices are printed, no pharmacy is named, and its policies print a placeholder address.

Operating entity Metaboost Rx LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSMetaboost Rx's semaglutide product page; Metaboost Rx's website
S2Prescription gatingPASSMetaboost Rx's website; Metaboost Rx's about page; Metaboost Rx's semaglutide product page; Metaboost Rx's terms
S3Pharmacy identificationFAILMetaboost Rx's semaglutide product page; Metaboost Rx's terms
S4Compounding disclosurePASSMetaboost Rx's website; Metaboost Rx's peptides page
S5Analytical documentationFAILMetaboost Rx's peptides page; Metaboost Rx's terms
S6Business addressFAILMetaboost Rx's contact page; Metaboost Rx's terms; Metaboost Rx's privacy page
S7Price disclosurePASSMetaboost Rx's peptides page; Metaboost Rx's website
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews and authorizes each consultation and directs every dose, and the footer says every prescription decision is made by an independent licensed practitioner.Source: Metaboost Rx's semaglutide product page; Metaboost Rx's website.
S2PASSThe home page lists a secure online assessment of history, goals and baseline as the first step and says a buyer who is not approved is not charged, and the program answers say every program begins with an online consultation. The terms refund an order when the provider declines to prescribe.Source: Metaboost Rx's website; Metaboost Rx's about page; Metaboost Rx's semaglutide product page; Metaboost Rx's terms.
S3FAILNo filling pharmacy is named. The program pages, the footer and the terms refer only to partner compounding pharmacies and state-licensed compounding pharmacies.Source: Metaboost Rx's semaglutide product page; Metaboost Rx's terms.
S4PASSThe disclaimer at the foot of every page and the note beneath the peptides price list state that compounded medications are not FDA-approved, and the home page adds that compounded semaglutide and tirzepatide are not the same as the branded medications.Source: Metaboost Rx's website; Metaboost Rx's peptides page.
S5FAILNo certificate of analysis or lot document is published on the program pages, the peptide pages, the terms, the privacy policy or the HIPAA notice.Source: Metaboost Rx's peptides page; Metaboost Rx's terms.
S6FAILMetaboost Rx prints two different addresses for itself. The contact page gives Metaboost-Rx LLC at 2915 N. Classen Blvd, Ste 120-F #1232, Oklahoma City, OK 73106, while the terms and the privacy policy give Metaboost Rx LLC at 123 Example Street, Suite 100, Your City, WI, 92308, a placeholder.Source: Metaboost Rx's contact page; Metaboost Rx's terms; Metaboost Rx's privacy page.
S7PASSThe semaglutide injection from $149 a month, the tirzepatide injection from $199, the GLP-1 microdose from $199 and the oral GLP-1 from $229 a month. The home page prints the tirzepatide price of $199 beside $299 struck through, and its banner presents weight loss from $149 a month as a new patient offer. Tesamorelin from $299 a month, sermorelin and PT-141 from $249 and NAD+ from $199.Source: Metaboost Rx's peptides page; Metaboost Rx's website.
S8PASSNo FDA warning letter names Metaboost Rx or Metaboost Rx LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: semaglutide injection, tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+, PT-141.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141Who sells tesamorelin

Visit Metaboost Rx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.